Literature DB >> 26531195

SHV-129: A Gateway to Global Suppressors in the SHV β-Lactamase Family?

Marisa L Winkler1, Robert A Bonomo2.   

Abstract

Enzymes are continually evolving in response to environmental pressures. In order to increase enzyme fitness, amino acid substitutions can occur leading to a changing function or an increased stability. These evolutionary drivers determine the activity of an enzyme and its success in future generations in response to changing conditions such as environmental stressors or to improve physiological function allowing continual persistence of the enzyme. With recent warning reports on antibiotic resistance and multidrug resistant bacterial infections, understanding the evolution of β-lactamase enzymes, which are a large contributor to antibiotic resistance, is increasingly important. Here, we investigated a variant of the SHV β-lactamase identified from a clinical isolate of Escherichia coli in 2011 (SHV-129, G238S-E240K-R275L-N276D) to identify the first instance of a global suppressor substitution in the SHV β-lactamase family. We have used this enzyme to show that several evolutionary principles are conserved in different class A β-lactamases, such as active site mutations reducing stability and requiring compensating suppressor substitutions in order to ensure evolutionary persistence of a given β-lactamase. However, the pathway taken by a given β-lactamase in order to reach its evolutionary peak under a given set of conditions is likely different. We also provide further evidence for a conserved stabilizing substitution among class A β-lactamases, the back to consensus M182T substitution. In addition to expanding the spectrum of β-lactamase activity to include the hydrolysis of cefepime, the amino acid substitutions found in SHV-129 provide the enzyme with an excess of stability, which expands the evolutionary landscape of this enzyme and may result in further evolution to potentially include resistance to carbapenems or β-lactamase inhibitors. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution 2015. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  antibiotic resistance; global suppressors; protein evolution; β-lactamase

Mesh:

Substances:

Year:  2015        PMID: 26531195      PMCID: PMC4909130          DOI: 10.1093/molbev/msv235

Source DB:  PubMed          Journal:  Mol Biol Evol        ISSN: 0737-4038            Impact factor:   16.240


  43 in total

1.  Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs.

Authors:  Xiaojun Wang; George Minasov; Brian K Shoichet
Journal:  J Mol Biol       Date:  2002-06-28       Impact factor: 5.469

2.  A natural polymorphism in beta-lactamase is a global suppressor.

Authors:  W Huang; T Palzkill
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

3.  Exploring the role of a conserved class A residue in the Ω-Loop of KPC-2 β-lactamase: a mechanism for ceftazidime hydrolysis.

Authors:  Peter S Levitt; Krisztina M Papp-Wallace; Magdalena A Taracila; Andrea M Hujer; Marisa L Winkler; Kerri M Smith; Yan Xu; Michael E Harris; Robert A Bonomo
Journal:  J Biol Chem       Date:  2012-07-26       Impact factor: 5.157

4.  Ultrahigh resolution structure of a class A beta-lactamase: on the mechanism and specificity of the extended-spectrum SHV-2 enzyme.

Authors:  Michiyoshi Nukaga; Kayoko Mayama; Andrea M Hujer; Robert A Bonomo; James R Knox
Journal:  J Mol Biol       Date:  2003-04-18       Impact factor: 5.469

5.  Computed circular dichroism spectra for the evaluation of protein conformation.

Authors:  N Greenfield; G D Fasman
Journal:  Biochemistry       Date:  1969-10       Impact factor: 3.162

6.  Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.

Authors:  Marisa L Winkler; Krisztina M Papp-Wallace; Robert A Bonomo
Journal:  J Antimicrob Chemother       Date:  2015-05-08       Impact factor: 5.790

Review 7.  Cefepime: a reappraisal in an era of increasing antimicrobial resistance.

Authors:  Andrea Endimiani; Federico Perez; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2008-12       Impact factor: 5.091

8.  Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States.

Authors:  Yohei Doi; Yoon Soo Park; Jesabel I Rivera; Jennifer M Adams-Haduch; Ameet Hingwe; Emilia M Sordillo; James S Lewis; Wanita J Howard; Laura E Johnson; Bruce Polsky; James H Jorgensen; Sandra S Richter; Kathleen A Shutt; David L Paterson
Journal:  Clin Infect Dis       Date:  2012-11-13       Impact factor: 9.079

9.  A fitness cost associated with the antibiotic resistance enzyme SME-1 beta-lactamase.

Authors:  David C Marciano; Omid Y Karkouti; Timothy Palzkill
Journal:  Genetics       Date:  2007-06-11       Impact factor: 4.562

10.  Mutational studies on resurrected ancestral proteins reveal conservation of site-specific amino acid preferences throughout evolutionary history.

Authors:  Valeria A Risso; Fadia Manssour-Triedo; Asunción Delgado-Delgado; Rocio Arco; Alicia Barroso-delJesus; Alvaro Ingles-Prieto; Raquel Godoy-Ruiz; Jose A Gavira; Eric A Gaucher; Beatriz Ibarra-Molero; Jose M Sanchez-Ruiz
Journal:  Mol Biol Evol       Date:  2014-11-12       Impact factor: 16.240

View more
  5 in total

1.  Mutation S115T in IMP-Type Metallo-β-Lactamases Compensates for Decreased Expression Levels Caused by Mutation S119G.

Authors:  Charles J Zhang; Mohammad Faheem; Paulie Dang; Monica N Morris; Pooja Kumar; Peter Oelschlaeger
Journal:  Biomolecules       Date:  2019-11-11

Review 2.  Structure, Genetics and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM): a threat to public health.

Authors:  Asad U Khan; Lubna Maryam; Raffaele Zarrilli
Journal:  BMC Microbiol       Date:  2017-04-27       Impact factor: 3.605

3.  Mutations responsible for the carbapenemase activity of SME-1.

Authors:  Vidhu Agarwal; Akhilesh Tiwari; Pritish Varadwaj
Journal:  RSC Adv       Date:  2022-08-15       Impact factor: 4.036

Review 4.  A Review of SHV Extended-Spectrum β-Lactamases: Neglected Yet Ubiquitous.

Authors:  Apostolos Liakopoulos; Dik Mevius; Daniela Ceccarelli
Journal:  Front Microbiol       Date:  2016-09-05       Impact factor: 5.640

5.  Prevalence of extensive drug resistance in bacterial isolates harboring blaNDM-1 in Quetta Pakistan.

Authors:  Mohammad Din; Khan M Babar; Shabir Ahmed; Abdul Aleem; Dawood Shah; Dawood Ghilzai; Nazeer Ahmed
Journal:  Pak J Med Sci       Date:  2019 Jul-Aug       Impact factor: 1.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.